TuHURA Biosciences Company Profile, Contacts & Intelligence
TuHURA Biosciences Overview
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer. TuHURA’s Immune Fx™, or IFx™, personalized cancer vaccine technology is designed to “trick” the body’s immune system to attack tumor cells by making tumor cells look like bacteria thereby harnessing the power of the innate immune response by leveraging natural mechanisms conserved throughout evolution to recognize threats from foreign pathogens like bacteria or viruses. TuHURA’s personalized cancer vaccines are delivered either via intratumoral injection using The Company’s pDNA vaccine or tumor targeted via intravenous using The Company’s mRNA vaccine. TuHURA is leveraging its Delta receptor technology to develop first-in-class bi-functional antibody drug conjugates (ADCs), targeting Myeloid Derived Suppressor Cells (MDSCs) to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. The Company’s Delta receptor technology was developed at Moffitt Cancer Center, West Virginia University and TuHURA Biopharma.
- Headquarters
- Tampa, Fl, United States
- Website
- tuhurabio.com
- Industry
- Biotechnology Research
- Stock Symbol
- KTRA
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
TuHURA Biosciences Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
TuHURA Biosciences People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
TuHURA Biosciences Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to TuHURA Biosciences
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Veranova | Pharmaceutical Manufacturing | 582 | View company |
| Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | Biotechnology Research | 378 | View company |
| Artiva Biotherapeutics | Biotechnology Research | 104 | View company |
| Dianthus Therapeutics, Inc. | Biotechnology Research | 89 | View company |
| TRexBio | Biotechnology Research | 55 | View company |
| NOETIK | Biotechnology Research | 39 | View company |
| PTSI - Pharmaceutical Technical Solutions, Inc. | Pharmaceutical Manufacturing | 26 | View company |
| TuHURA Biosciences, Inc. | Biotechnology Research | 24 | View company |
| Newleos Therapeutics | Biotechnology Research | 19 | View company |
| Kintara Therapeutics, Inc. NASDAQ: KTRA | Biotechnology Research | 5 | View company |